Solid Biosciences (SLDB) Operating Leases (2019 - 2026)
Solid Biosciences' Operating Leases came in at $17.92 million for Q2 2026, down 11.1% from $20.16 million a year earlier and down 3.0% from the prior quarter.
Powered by 
Analysis
Solid Biosciences (SLDB) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Solid Biosciences' Operating Leases was $19.06 million, down 9.9% from FY2024.
- Operating Leases has declined in each of the last three years, though with a five-year compound annual growth rate of 51.1% (FY2020 to FY2025).
- Going back by year, Operating Leases was $21.16 million in FY2024 (-6.8%), $22.71 million in FY2023 (-6.5%), $24.28 million in FY2022 and $275,000 in FY2021 (-88.6%).
- The Q2 2026 figure represents the lowest quarterly Operating Leases since Q1 2022.
- Year-over-year, Operating Leases has declined for 13 consecutive quarters, with an average decline of 8.9% over the last eight quarters.
- Over the past five years, the year-over-year decline in Operating Leases ranged from 3.7% (Q2 2023) to 96.5% (Q1 2022).
- Business Quant data shows SLDB's Operating Leases at $18.48 million (Q1 2026), $19.06 million (Q4 2025) and $19.62 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.80 Bn | 1,100.39 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 614.01 Bn | 532.53 Bn | 17.26 Bn |
| 3 | AbbVie | 503.59 Bn | 476.70 Bn | 12.70 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.81 Bn | 261.80 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.50 Bn | 235.19 Bn | 12.86 Bn |
| 7 | Amgen | 236.24 Bn | 191.64 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.15 Bn | 165.35 Bn | 6.22 Bn |
| 9 | Pfizer | 170.16 Bn | 116.81 Bn | 10.94 Bn |
| 10 | Solid Biosciences | 928.23 Mn | -254.12 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.92 Mn |
| Mar 31, 2026 | 18.48 Mn |
| Dec 31, 2025 | 19.06 Mn |
| Sep 30, 2025 | 19.62 Mn |
| Jun 30, 2025 | 20.16 Mn |
| Mar 31, 2025 | 20.66 Mn |
| Dec 31, 2024 | 21.16 Mn |
| Sep 30, 2024 | 21.64 Mn |
| Jun 30, 2024 | 22.10 Mn |
| Mar 31, 2024 | 22.53 Mn |
| Dec 31, 2023 | 22.71 Mn |
| Sep 30, 2023 | 23.19 Mn |
| Jun 30, 2023 | 23.65 Mn |
| Mar 31, 2023 | 23.91 Mn |
| Dec 31, 2022 | 24.28 Mn |
| Sep 30, 2022 | 24.27 Mn |
| Jun 30, 2022 | 24.54 Mn |
| Mar 31, 2022 | 70,000.00 |
| Dec 31, 2021 | 275,000.00 |
| Sep 30, 2021 | 468,000.00 |
API Access
Solid Biosciences Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=SLDB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "SLDB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=SLDB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();